Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma.
109
mentions
- X 106
- News 2
- YouTube 1
PubHawk tracks social media discussions for 4 articles by authors named Geoffrey R Oxnard.
Mentions
Extended reach
Total likes
Video views
Tracked by PubHawk
From PubMed
Searching PubMed…